Indiana University Melvin and Bren Simon Cancer Center

Researchers

Research Programs Member Directory Become a Member Shared Facilities Angiogenesis, Endothelial & Pro-Angiogenic Cell Core Behavioral and Cancer Control Recruitment Core Biological Microscopy Biostatistics & Data Management Bio-Plex Center for Computational Biology and Bioinformatics Chemical Genomics Clinical Pharmacology Analytical Core Clinical Research Office Services Policies & Procedures Contact Flow Cytometry In Vivo Biomedical Imaging In Vivo Therapeutics Protein Analysis Research Center Therapeutic Validation Tissue Procurement and Distribution Transgenic and Knock-Out Mouse Translational Genomics Funding Opportunities Research Resources Signature Centers

You are here: HOME > Researchers > Facilities > Clinical Research Office

Clinical Research Office

The IU Simon Cancer Center has a large clinical trials program. In 2011, 2,302 patients were enrolled on clinical trials. The Clinical Research Office (CRO) is a shared resource available to all clinical investigators of the IU Simon Cancer Center whose services enable the efficient and safe conduct of adult and pediatric trials.

The mission of the Indiana University Melvin and Bren Simon Cancer Center (IUSCC) Clinical Research Office is to provide the necessary support to facilitate the conduct of quality clinical research by IUSCC translational clinical investigators. The CRO is a shared resource that is available to all members of the cancer center. The CRO also coordinates the scientific review of proposed trials by the Protocol Review and Monitoring System (SRC) of the cancer center.

The experienced support staff of the Clinical Research Office provides essential services, which enable the clinical investigator to efficiently conduct clinical trials in an increasingly complex regulatory and financial environment. The CRO provides a comprehensive range of services. The complexity of both clinical and translational trials continues to increase at a time when the conduct of trials is under greater regulatory scrutiny. These services begin in the early stages of trial development and continue throughout the study implementation, publication, and long-term follow-up. There is a need to maximize the information yield of clinical trials and to assure human safety. The CRO facilitates the conduct of a successful clinical trials program of this magnitude by providing a professionally diverse, talented staff and highly efficient organization.